{"nct_id":"NCT01633060","title":"A Phase III Study of BKM120 With Fulvestrant in Patients With HR+,HER2-, AI Treated, Locally Advanced or Metastatic Breast Cancer Who Progressed on or After mTORi","status":"TERMINATED","status_verified_date":"2019-01","start_date":"2012-10-03","start_date_type":"ACTUAL","primary_completion_date":"2016-05-23","primary_completion_date_type":"ACTUAL","completion_date":"2017-09-21","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["NVS"]}